hero section gradient
15 handpicked stocks

Mexico's Stable Rise

Mexico's economy is showing impressive signs of stability with a narrowing current account deficit. This collection features companies set to thrive from a potentially stronger peso, increased consumer spending, and renewed investor confidence in Mexico's economic future.

Author avatar

Han Tan | Market Analyst

Published on June 30

Your Basket's Financial Footprint

Summary and investor key takeaways for the provided basket market capitalisation data.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and returns that track broad market moves, reducing idiosyncratic risk.
  • Suitable as a core holding within diversified portfolios, not as a high-risk speculative allocation.
  • Tends to offer steady, long-term value rather than rapid, short-term explosive gains.
Total Market Cap
  • FMX: $30.53B

  • KOF: $17.67B

  • CX: $13.81B

  • Other

About This Group of Stocks

1

Our Expert Thinking

Mexico's reduced current account deficit (now $12.6 billion) signals improved economic stability and fiscal health. This creates an attractive investment opportunity in companies that directly benefit from a strengthening peso, increased domestic consumption, and a more favorable business environment.

2

What You Need to Know

This collection focuses on domestically-oriented Mexican businesses spanning consumer goods, beverage production, building materials, and infrastructure. These sectors are well-positioned to capitalize on Mexico's economic improvements through increased consumer spending and renewed investor confidence.

3

Why These Stocks

These companies were carefully selected for their direct exposure to Mexico's improving economic landscape. The portfolio includes established leaders in consumer staples, industrials, and infrastructure that stand to benefit from a stronger peso, increased domestic investment, and overall economic recovery.

Why You'll Want to Watch These Stocks

📈

Peso Power Play

Mexico's strengthening economic fundamentals could boost the peso, potentially supercharging returns for these domestic companies that earn in pesos but may have some costs in dollars.

🔍

Hidden Value Opportunity

Many investors overlook Mexico's improving fiscal position, creating a potential opportunity to get in before broader market recognition drives up valuations in these carefully selected stocks.

🌎

Nearshoring Advantage

Mexico's stable economy makes it an increasingly attractive manufacturing alternative to Asia, positioning these companies to potentially benefit from the global supply chain realignment trend.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions